Taking a look at what insiders are doing to gauge the EyePoint Pharmaceuticals Inc (EYPT)’s direction
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. EyePoint Pharmaceuticals Inc shares valued at $5,954 were sold by Jones David Scott on Feb 02 ’24. At $28.49 per share, Jones David Scott sold 209 shares. The insider’s holdings dropped […]
EyePoint Pharmaceuticals Inc [EYPT] SVP & Chief Commercial Officer sales 209 shares for $5954.0.
EyePoint Pharmaceuticals Inc’s recently made public that its SVP & Chief Commercial Officer Jones David Scott unloaded Company’s shares for reported $5954.0 on Feb 02 ’24. In the deal valued at $28.49 per share,209 shares were sold. As a result of this transaction, Jones David Scott now holds 37,962 shares worth roughly $0.81 million. Then, […]
EYPT’s short interest reaches 6.58 million shares on Mar 15, 2024
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals Inc shares valued at $5,954 were sold by Jones David Scott on Feb 02 ’24. At $28.49 per share, Jones David Scott sold 209 shares. The insider’s holdings dropped to 37,962 shares worth approximately $0.87 […]
EyePoint Pharmaceuticals Inc (EYPT) rating initates by JP Morgan
EyePoint Pharmaceuticals Inc’s filing revealed that its SVP & Chief Commercial Officer Jones David Scott unloaded Company’s shares for reported $5954.0 on Feb 02 ’24. In the deal valued at $28.49 per share,209 shares were sold. As a result of this transaction, Jones David Scott now holds 37,962 shares worth roughly $0.79 million. Then, Paggiarino […]
Negative sentiment towards EYPT reflected by a jump of 27.81% in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals Inc shares valued at $5,954 were sold by Jones David Scott on Feb 02 ’24. At $28.49 per share, Jones David Scott sold 209 shares. The insider’s holdings dropped to 37,962 shares worth approximately $0.79 […]
EyePoint Pharmaceuticals Inc [EYPT] Investment Appeal on the Rise
EyePoint Pharmaceuticals Inc’s recent filing unveils that its SVP & Chief Commercial Officer Jones David Scott unloaded Company’s shares for reported $5954.0 on Feb 02 ’24. In the deal valued at $28.49 per share,209 shares were sold. As a result of this transaction, Jones David Scott now holds 37,962 shares worth roughly $0.78 million. Then, […]
EyePoint Pharmaceuticals Inc [EYPT] Stock sold by Insider Jones David Scott for $5954.0
EyePoint Pharmaceuticals Inc’s recent filing unveils that its SVP & Chief Commercial Officer Jones David Scott unloaded Company’s shares for reported $5954.0 on Feb 02 ’24. In the deal valued at $28.49 per share,209 shares were sold. As a result of this transaction, Jones David Scott now holds 37,962 shares worth roughly $0.78 million. Then, […]
These 4 Companies Are Ending the Week Strong
The NASDAQ’s 1.0% gain led the market yesterday, and the S&P 500 and DJIA posted fractional gains. After passing its previous all-time high earlier in the week, markets aren’t sure where to go from here. Stocks are still performing strongly in spite of the inherent risks, but that could change on the drop of a […]
5 Breakout Stocks to Watch Today
The S&P 500 pulled back from its newly acquired all-time high yesterday and 0.4% on the session. The NASDAQ also declined 0.5% and the Dow lost 0.3%. The uncertainty regarding stimulus talks in Washington is also beginning to weigh on the market. Negotiations between both parties seem to be hopelessly deadlocked, and investors are beginning […]
